Gerd Hasenfuss
Dept. of Cardiology and Pneumology
Heart Center Göttingen
Robert-Koch-Strasse 40
37075 Goettingen
Germany
Name/email consistency: high
- Mechanism of action of the new anti-ischemia drug ranolazine. Hasenfuss, G., Maier, L.S. Clin. Res. Cardiol (2008)
- Influence of pyruvate on contractile performance and Ca(2+) cycling in isolated failing human myocardium. Hasenfuss, G., Maier, L.S., Hermann, H.P., Lüers, C., Hünlich, M., Zeitz, O., Janssen, P.M., Pieske, B. Circulation (2002)
- Calcium cycling in congestive heart failure. Hasenfuss, G., Pieske, B. J. Mol. Cell. Cardiol. (2002)
- Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Hasenfuss, G., Schillinger, W., Lehnart, S.E., Preuss, M., Pieske, B., Maier, L.S., Prestle, J., Minami, K., Just, H. Circulation (1999)
- Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Hasenfuss, G., Pieske, B., Castell, M., Kretschmann, B., Maier, L.S., Just, H. Circulation (1998)